Clinical Trial Update: Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases [Phase 1]

View source ↗

Summary

An early-phase clinical trial update examining the combination of diphencyprone with an immune checkpoint inhibitor for cutaneous metastases, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Metastases

Drugs mentioned

• Diphencyprone (diphencyprone)

Snippet

Sponsor: Nicholas Gulati | Conditions: Cutaneous Metastases | Phase 1 | Status: RECRUITING